J. D. Rothermel

1.1k total citations
24 papers, 930 citations indexed

About

J. D. Rothermel is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, J. D. Rothermel has authored 24 papers receiving a total of 930 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 11 papers in Molecular Biology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in J. D. Rothermel's work include Cancer Treatment and Pharmacology (14 papers), Colorectal Cancer Treatments and Studies (8 papers) and Lung Cancer Treatments and Mutations (4 papers). J. D. Rothermel is often cited by papers focused on Cancer Treatment and Pharmacology (14 papers), Colorectal Cancer Treatments and Studies (8 papers) and Lung Cancer Treatments and Mutations (4 papers). J. D. Rothermel collaborates with scholars based in United States, Switzerland and Germany. J. D. Rothermel's co-authors include L Botelho, Bernd Jastorff, Robert V. Coombs, Wojciech J. Stec, Janina Baraniak, Markus Wartmann, John Hohneker, Tianling Chen, Tse‐Ching Chen and Eric H. Rubin and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Annals of Surgery.

In The Last Decade

J. D. Rothermel

23 papers receiving 885 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. D. Rothermel United States 14 492 232 179 127 94 24 930
Carol L. Sable United States 12 1.3k 2.6× 242 1.0× 162 0.9× 161 1.3× 140 1.5× 14 1.7k
Alexandra King United States 14 612 1.2× 270 1.2× 148 0.8× 124 1.0× 113 1.2× 16 1.1k
Bettina Dümmler Switzerland 9 1.2k 2.5× 218 0.9× 78 0.4× 168 1.3× 101 1.1× 9 1.6k
Ron Kriz United States 17 1.1k 2.3× 170 0.7× 162 0.9× 271 2.1× 89 0.9× 23 1.5k
Lewis J. Stafford United States 20 1.1k 2.2× 245 1.1× 122 0.7× 160 1.3× 58 0.6× 23 1.5k
Pauline R.M. Dobson United Kingdom 18 548 1.1× 308 1.3× 122 0.7× 43 0.3× 56 0.6× 43 1.1k
Noboru Takami Japan 17 456 0.9× 150 0.6× 133 0.7× 239 1.9× 97 1.0× 26 768
Fabrizio Loreni Italy 30 1.7k 3.4× 248 1.1× 104 0.6× 142 1.1× 93 1.0× 58 2.0k
Hakryul Jo United States 16 914 1.9× 171 0.7× 94 0.5× 232 1.8× 65 0.7× 19 1.3k
Ronald J. Uhing United States 20 1.1k 2.2× 165 0.7× 207 1.2× 283 2.2× 220 2.3× 33 1.7k

Countries citing papers authored by J. D. Rothermel

Since Specialization
Citations

This map shows the geographic impact of J. D. Rothermel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. D. Rothermel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. D. Rothermel more than expected).

Fields of papers citing papers by J. D. Rothermel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. D. Rothermel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. D. Rothermel. The network helps show where J. D. Rothermel may publish in the future.

Co-authorship network of co-authors of J. D. Rothermel

This figure shows the co-authorship network connecting the top 25 collaborators of J. D. Rothermel. A scholar is included among the top collaborators of J. D. Rothermel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. D. Rothermel. J. D. Rothermel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rubin, Eric H., J. D. Rothermel, Fisseha Tesfaye, et al.. (2005). Phase I Dose-Finding Study of Weekly Single-Agent Patupilone in Patients With Advanced Solid Tumors. Journal of Clinical Oncology. 23(36). 9120–9129. 79 indexed citations
2.
Eder, Joseph P., Rocio García‐Carbonero, Jeffrey W. Clark, et al.. (2004). A Phase I Trial of Daily Oral 4′-N-Benzoyl-Staurosporine in Combination with Protracted Continuous Infusion 5-Fluorouracil in Patients with Advanced Solid Malignancies. Investigational New Drugs. 22(2). 139–150. 29 indexed citations
3.
Wójtowicz, Magdalena, et al.. (2004). Phase I dose-escalation trial investigating the safety and tolerability of EPO906 plus estramustine in patients with advanced cancer. Journal of Clinical Oncology. 22(14_suppl). 4623–4623. 10 indexed citations
4.
Dumez, Herlinde, A.T. van Oosterom, J. D. Rothermel, Robert Mull, & A H Calvert. (2004). Phase Ib/II dose-escalation trial evaluating the safety and tolerability of EPO906 plus capecitabine in patients with advanced cancer. Journal of Clinical Oncology. 22(14_suppl). 2093–2093. 5 indexed citations
5.
Wójtowicz, Magdalena, et al.. (2004). Phase I dose-escalation trial investigating the safety and tolerability of EPO906 plus estramustine in patients with advanced cancer. Journal of Clinical Oncology. 22(14_suppl). 4623–4623. 2 indexed citations
6.
Rinehart, J. J., J. D. Rothermel, Joshua C. Anderson, & Patricia LoRusso. (2004). Phase I dose-escalation trial investigating the safety and tolerability of EPO906 plus gemcitabine in patients with advanced cancer. Journal of Clinical Oncology. 22(14_suppl). 3100–3100. 3 indexed citations
7.
Rinehart, J. J., J. D. Rothermel, Jeanne E. Anderson, & Patricia LoRusso. (2004). Phase I dose-escalation trial investigating the safety and tolerability of EPO906 plus gemcitabine in patients with advanced cancer. Journal of Clinical Oncology. 22(14_suppl). 3100–3100. 8 indexed citations
8.
Hussain, A., et al.. (2004). A Phase IIa trial of weekly EPO906 in patients with hormone-refractory prostate cancer (HPRC). Journal of Clinical Oncology. 22(14_suppl). 4563–4563. 23 indexed citations
9.
Woltering, Eugene A., James M. Lewis, P Maxwell, et al.. (2003). Development of a Novel In Vitro Human Tissue-Based Angiogenesis Assay to Evaluate the Effect of Antiangiogenic Drugs. Annals of Surgery. 237(6). 790–800. 28 indexed citations
10.
Rothermel, J. D., Markus Wartmann, Tse‐Ching Chen, & John Hohneker. (2003). EPO906 (epothilone B): A promising novel microtubule stabilizer. Seminars in Oncology. 30(3). 51–55. 46 indexed citations
11.
Rothermel, J. D., Markus Wartmann, Tianling Chen, & John Hohneker. (2003). EPO906 (epothilone B): A promising novel microtubule stabilizer. Seminars in Oncology. 30(3 Suppl 6). 51–55. 32 indexed citations
12.
Woltering, Eugene A., James D. Lewis, Yi‐Zarn Wang, et al.. (2003). . Annals of Surgery. 237(6). 790–800. 1 indexed citations
13.
Reinhard, Björn M., Alexander Becker, J. D. Rothermel, & Hans Faillard. (1992). 2-α-(N-Dansyl-4-aminophenylthio)-N-acetyl-9-O-acetylneuraminic Acid. A New Specific and Highly Sensitive Substrate in Sialate-O-Acetylesterase Assay. Biological Chemistry Hoppe-Seyler. 373(1). 63–68. 4 indexed citations
14.
Rothermel, J. D. & Hans Faillard. (1989). Phase-Transfer-Catalysed Synthesis of N-Acetylneuraminic Acid α-Thioketosides and Inhibitor Studies withClostridium perfringensSialidase. Biological Chemistry Hoppe-Seyler. 370(2). 1077–1084. 15 indexed citations
15.
Botelho, L, et al.. (1988). Inhibition of cAMP-dependent protein kinase by adenosine cyclic 3‘-, 5‘-phosphorodithioate, a second cAMP antagonist.. Journal of Biological Chemistry. 263(11). 5301–5305. 28 indexed citations
16.
17.
Botelho, L, J. D. Rothermel, Robert V. Coombs, & Bernd Jastorff. (1988). [15] cAMP analog antagonists of cAMP action. Methods in enzymology on CD-ROM/Methods in enzymology. 159. 159–172. 172 indexed citations
18.
Rothermel, J. D., Bernd Jastorff, & L Botelho. (1984). Inhibition of glucagon-induced glycogenolysis in isolated rat hepatocytes by the Rp diastereomer of adenosine cyclic 3‘,5‘-phosphorothioate.. Journal of Biological Chemistry. 259(13). 8151–8155. 91 indexed citations
19.
20.
Rothermel, J. D., et al.. (1977). Daily changes in peripheral plasma progesterone concentrations in pregnant and pseudopregnant rabbits. Life Sciences. 20(8). 1333–1340. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carol L. Sable Breakdown of academic impact, for papers by Alexandra King Breakdown of academic impact, for papers by Bettina Dümmler Breakdown of academic impact, for papers by Ron Kriz Breakdown of academic impact, for papers by Lewis J. Stafford Breakdown of academic impact, for papers by Pauline R.M. Dobson Breakdown of academic impact, for papers by Noboru Takami Breakdown of academic impact, for papers by Fabrizio Loreni Breakdown of academic impact, for papers by Hakryul Jo Breakdown of academic impact, for papers by Ronald J. Uhing
Rankless by CCL
2026